GABA
Alzheimer’s disease
GABA-mimetics
GABAA receptor
homotaurine
inflammation
taurine
tramiprosate
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2023
2023
Historique:
received:
01
08
2023
accepted:
20
11
2023
medline:
29
12
2023
pubmed:
29
12
2023
entrez:
29
12
2023
Statut:
epublish
Résumé
Dementia and autoimmune diseases are prevalent conditions with limited treatment options. Taurine and homotaurine (HT) are naturally occurring sulfonate amino acids, with taurine being highly abundant in animal tissues, but declining with age in the blood. HT is a blood-brain barrier permeable drug under investigation for Alzheimer's disease. HT also has beneficial effects in a mouse model of multiple sclerosis likely through an anti-inflammatory mechanism mediated by GABA
Identifiants
pubmed: 38155909
doi: 10.3389/fphar.2023.1271203
pii: 1271203
pmc: PMC10752957
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1271203Informations de copyright
Copyright © 2023 Meera, Uusi-Oukari, Lipshutz and Wallner.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.